3.1. Subject Baseline Characteristics
In total, 117 volunteers were initially selected to participate in this clinical trial, of whom 17 were excluded during screening. Therefore, the DW2010 and placebo groups comprised 50 subjects each. However, during the investigation, 15 subjects from the DW2010 group who withdrew consent or met exclusion criteria, or who exhibited low trial compliance (≤65%), were excluded from the clinical trial. Similarly, 11 subjects from the placebo group were removed from the assessment. Therefore, 74 subjects (DW2010 group, 